The management of severe primary graft failure after cardiac transplantation

J Cardiothorac Vasc Anesth. 2009 Apr;23(2):203-5. doi: 10.1053/j.jvca.2007.12.010. Epub 2008 Mar 14.

Authors

Daniela Hauer¹, Andres Beiras-Fernandez, Felix Kur, Marion Weis, Michael Schmoeckel, Florian C Weis

Affiliation

¹ Department of Anesthesiology, University Hospital Grosshadern, Ludwig-Maximilians University, Munich, Germany.

PMID: 18834785
DOI: 10.1053/j.jvca.2007.12.010

No abstract available

Publication types

Case Reports

MeSH terms

Cardiomyopathy, Dilated / surgery
Cardiopulmonary Bypass
Extracorporeal Membrane Oxygenation
Graft Survival*
Heart Transplantation / adverse effects*
Heart Transplantation / physiology
Hemodynamics / drug effects
Humans
Hydrazones / therapeutic use*
Male
Middle Aged
Postoperative Complications / drug therapy*
Pyridazines / therapeutic use*
Simendan
Treatment Failure
Vasodilator Agents / therapeutic use*

Substances

Hydrazones
Pyridazines
Vasodilator Agents
Simendan